Search results for "Static"

showing 10 items of 1528 documents

Radium-223 treatment in castration resistant bone metastatic prostate cancer. Should be the primary tumor always treated?

2019

Introduction: Radium-223 (223Ra) improves symptoms and survival in patients with bone metastatic castration-resistant prostate cancer (mCRPC). Study aim: To evaluate the impact of a previous radical prostatectomy (RP) on the outcome of 223Ra therapy in mCRPC patients. The primary prostate tumor left untreated could progress during 223Ra treatment. Materials and methods: mCRPC symptomatic patients treated with 223Ra were enrolled. Luteinizing Hormone-Releasing Hormone analogue was maintained. No other anticancer therapy was given. 223Ra was administered i.v. at the dose of 55 kBq/kg every 4 weeks for 6 cycles. Patients were stratified according to previous RP or not. Hematological toxicity w…

Radium-223Malemedicine.medical_specialtyUrologymedicine.medical_treatment030232 urology & nephrologyUrologyAntineoplastic AgentsBone NeoplasmsSettore MED/24 - UrologiaPrimary tumor03 medical and health sciencesProstate cancer0302 clinical medicineProstateRadium-222medicineHumansAgedProstatectomyRadiotherapybusiness.industryProstatectomyProstateChemoradiotherapy Adjuvantmedicine.diseasePrognosisRadical prostatectomyPrimary tumorSurvival AnalysisRadiation therapyProstatic Neoplasms Castration-Resistantmedicine.anatomical_structureTreatment OutcomeOncology030220 oncology & carcinogenesisConcomitantDisease ProgressionCastration resistant prostate cancerNeoplasm GradingRadiopharmaceuticalsbusinessmedicine.drugHormoneFollow-Up StudiesRadiumUrologic oncology
researchProduct

Lattice Dynamics Study of HgGa2Se4 at High Pressures

2013

We report on Raman scattering measurements in mercury digallium selenide (HgGa2Se4) up to 25 GPa. We also performed, for the low-pressure defect-chalcopyrite structure, lattice-dynamics ab initio calculations at high pressures which agree with experiments. Measurements evidence that the semiconductor HgGa2Se4 exhibits a pressure-induced phase transition above 19 GPa to a previously undetected structure. This transition is followed by a transformation to a Raman-inactive phase above 23.4 GPa. On downstroke from 25 GPa until 2.5 GPa, a broad Raman spectrum was observed, which has been attributed to a fourth phase, and whose pressure dependence was followed during a second upstroke. Candidate …

Raman scatteringLattice dynamicsHydrostatic pressureAb initioInitio molecular-dynamicssingle crystalsMolecular physicssymbols.namesakeX-Ray DiffractionPhysical and Theoretical ChemistryHydrostatic pressureValenciaOptical propertiesCondensed matter physicsbiologyChemistrybiology.organism_classificationSurfaces Coatings and FilmsElectronic Optical and Magnetic MaterialsPhonon modesGeneral EnergySemiconductorsFISICA APLICADAAb initioX-ray crystallographysymbolsInduced phase-transitionsRaman scatteringThe Journal of Physical Chemistry C
researchProduct

Blocking of an ion channel by a highly charged drug: Modeling the effects of applied voltage, electrolyte concentration, and drug concentration

2005

We present a simple physical model to estimate the blocked pore probability of an ion channel that can be blocked by a highly charged drug in solution. The model is inspired by recent experimental work on the blocking of the ${\mathrm{PA}}_{63}$ channel, involved in the anthrax toxin infection, by a highly charged drug [Karginov et al. PNAS 102, 15075 (2005)]. The drug binding to the pore is highly specific but the strong dependence of blocking on the applied voltage and electrolyte concentration suggests that long range electrostatic interactions are important. Since basic electrostatic concepts rather than detailed molecular models are considered, the microscopic details of the channel bl…

Range (particle radiation)Materials scienceDose-Response Relationship DrugMolecular modelStatic ElectricityElectrolyteHydrogen-Ion ConcentrationElectrostaticsBlocking (statistics)Models BiologicalIon ChannelsMembrane PotentialsElectrolytesElectromagnetic FieldsDrug concentrationModels ChemicalPharmaceutical PreparationsChemical physicsElectrochemistryComputer SimulationIon Channel GatingIon channelVoltagePhysical Review E
researchProduct

cis-bromination of alkynes without cationic intermediates

2005

Reaction mechanismMolecular StructureAcetyleneHydrocarbons HalogenatedChemistryElectrophilic additionStatic ElectricityCationic polymerizationHalogenationGeneral ChemistryBromineCatalysisBromine CompoundsIsomerismModels ChemicalAlkynesSolventsThermodynamicsOrganic chemistry
researchProduct

Demographic and clinical data in acquired hemophilia A

2012

Summary.  Background:  Acquired hemophilia A (AHA) is a rare autoimmune disease caused by autoantibodies against coagulation factor VIII and characterized by spontaneous hemorrhage in patients with no previous family or personal history of bleeding. Although data on several AHA cohorts have been collected, limited information is available on the optimal management of AHA. Objectives:  The European Acquired Hemophilia Registry (EACH2) was established to generate a prospective, large-scale, pan-European database on demographics, diagnosis, underlying disorders, bleeding characteristics, treatment and outcome of AHA patients. Results:  Five hundred and one (266 male, 235 female) patients from …

RegistrieMalePediatricsdiagnosismedicine.medical_treatmentHemostatic TechniqueKaplan-Meier EstimateregistryTHERAPYSettore MED/15 - Malattie Del SangueImmunosuppressive AgentIMMUNOADSORPTIONRisk FactorsPregnancy80 and overProspective StudiesRegistriesProspective cohort studyhealth care economics and organizationsAged 80 and overtreatmentImmunosuppressionHematologyMiddle AgedFACTOR-VIII INHIBITORAcquired hemophilia; Demographics; Diagnosis; Outcome; Registry; Treatment; Aged; Aged 80 and over; Autoantibodies; Chi-Square Distribution; Europe; Factor VIII; Female; Hemostatic Techniques; Humans; Immunosuppressive Agents; Kaplan-Meier Estimate; Male; Middle Aged; Pregnancy; Prospective Studies; Registries; Risk Assessment; Risk Factors; Treatment Outcome; Hemophilia A; HemorrhageAutoantibodieEuropeTreatment Outcomeacquired hemophilia; demographics; diagnosis; outcome; registry; treatmentoutcomeINTRAVENOUS GAMMA-GLOBULINFemaleacquired hemophiliaImmunosuppressive AgentsHumanmedicine.medical_specialtyHemorrhageHemophilia AMalignancyRisk Assessmenthemophilia registrydemographicsmedicineHumansMETAANALYSISAutoantibodiesAgedAutoimmune diseasePregnancyChi-Square DistributionFactor VIIIHemostatic Techniquesbusiness.industryRisk FactorAutoantibodymedicine.diseaseSurgeryProspective StudieHemostasisbusinessChi-squared distributionJournal of Thrombosis and Haemostasis
researchProduct

The finite element implementation of 3D fractional viscoelastic constitutive models

2018

Abstract The aim of this paper is to present the implementation of 3D fractional viscoelastic constitutive theory presented in Alotta et al., 2016 [1]. Fractional viscoelastic models exactly reproduce the time dependent behaviour of real viscoelastic materials which exhibit a long “fading memory”. From an implementation point of view, this feature implies storing the stress/strain history throughout the simulations which may require a large amount of memory. We propose here a number of strategies to effectively limit the memory required. The form of the constitutive equations are summarized and the finite element implementation in a Newton-Raphson integration scheme is described in detail. …

RelaxationComputer scienceSubroutineConstitutive equation3D constitutive models; Creep; Fractional viscoelasticity; Numerical modelling; Relaxation; Analysis; Engineering (all); Computer Graphics and Computer-Aided Design; Applied Mathematics02 engineering and technologyViscoelasticityStress (mechanics)Engineering (all)0203 mechanical engineeringFractional viscoelasticityApplied mathematicsLimit (mathematics)Applied MathematicsGeneral EngineeringAnalysiCreep021001 nanoscience & nanotechnologyComputer Graphics and Computer-Aided DesignFinite element method020303 mechanical engineering & transportsNumerical modellingBenchmark (computing)3D constitutive model0210 nano-technologyAnalysisQuasistatic process
researchProduct

Effect of application time and concentration of silver diamine fluoride on the enamel remineralization

2021

Background Silver diamine fluoride has attracted attention because of its clinical success in arresting dental caries. Thus, the aim of this study was to evaluate the effect of different application times and concentrations of silver diamine fluoride (SDF) on deciduous tooth enamel remineralization. Material and Methods Blocks of deciduous tooth enamel were categorized into six groups of 11 each: 2 control groups: intact enamel, and demineralized enamel; 38% SDF and 30% SDF which were subdivided according to application times (1 and 3 min). The microhardness of samples was determined, and all groups except the intact enamel group were subjected to pH cycling to produce initial carious lesio…

RemineralisationEnamel paintChemistrybusiness.industryResearchDeciduous toothDentistryTooth RemineralizationApplication timeOperative Dentistry and Endodonticsstomatognathic diseasesstomatognathic systemvisual_artvisual_art.visual_art_mediumCariostatic AgentsSilver diamine fluoridePrimary ToothbusinessGeneral DentistryUNESCO:CIENCIAS MÉDICASJournal of Clinical and Experimental Dentistry
researchProduct

Impact of prognostic factors on long-term outcomes in metastatic breast cancer (MBC) patients (pts) receiving bevacizumab (B) plus paclitaxel as firs…

2014

e12007 Background: B combined with chemotherapy (CT) significantly improves progression-free survival (PFS) and response rate (RR) vs CT alone in the first-line treatment of HER2-negative MBC. In a...

Response rate (survey)OncologyCancer Researchmedicine.medical_specialtyChemotherapyBevacizumabbusiness.industryFirst linemedicine.medical_treatmentMedizinmedicine.diseaseMetastatic breast cancerSurgerychemistry.chemical_compoundOncologyPaclitaxelchemistryInternal medicinemedicineLong term outcomesCytotoxic T cellskin and connective tissue diseasesbusinessneoplasmsmedicine.drugJournal of Clinical Oncology
researchProduct

Analysis according to prognostic factors in patients (pts) treated with first-line bevacizumab (BEV) combined with paclitaxel (PAC) for HER2-negative…

2012

1077 Background: 1st-line BEV combined with weekly PAC significantly improves progression-free survival (PFS) and response rate (RR) vs PAC alone in HER2-negative mBC, as shown in E2100. We analyzed data from a German routine oncology practice study of 1st-line BEV–PAC according to prognostic factors. Methods: Pts who had received no prior chemotherapy for mBC received BEV–PAC according to the European label. Efficacy and safety were documented for up to 1 y (or until progression, death, or BEV discontinuation if earlier) with additional long-term follow-up. Efficacy was analyzed in clinically important subgroups. Results: Efficacy data were available for 818 pts. The median duration of fo…

Response rate (survey)OncologyCancer Researchmedicine.medical_specialtyChemotherapyeducation.field_of_studyBevacizumabbusiness.industrymedicine.medical_treatmentPopulationmedicine.diseaseMetastatic breast cancerDiscontinuationchemistry.chemical_compoundOncologyPaclitaxelchemistryInternal medicinemedicineIn patientbusinesseducationmedicine.drugJournal of Clinical Oncology
researchProduct

Phenomenologies of Trust

2019

Aim of the paper is to compare different phenomenological accounts of the phenomenon of trust. After moving from the “noematic” observation of trust as embedded in the world, toward the “noetic” consideration of trust as a subjective act, we introduce the view of trust as a specific kind of perceptive experience giving the person as a totality and being characterized by a displacing double intentionality. Trust is therefore grasped as a teleological intentional process. This requires a phenomenological-genetic approach and challenges us to overcome the restrictions imposed by a static phenomenology of trust. The genetic approach focuses on trust as a grounding and selffostering experience t…

ResponsibilityGenetic PhenomenologyDouble intentionalityStatic PhenomenologySettore M-FIL/03 - Filosofia MoraleSocial VitalityPolitical Phenomenology
researchProduct